ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,922,763 | +49.4% | 71,558 | +98.2% | 0.01% | 0.0% |
Q2 2023 | $1,287,148 | +4.2% | 36,095 | -25.8% | 0.01% | 0.0% |
Q1 2023 | $1,234,897 | +133.0% | 48,618 | +321.8% | 0.01% | +25.0% |
Q1 2022 | $530,000 | -72.8% | 11,526 | -51.0% | 0.00% | -81.8% |
Q2 2021 | $1,948,000 | +472.9% | 23,520 | +339.1% | 0.02% | +100.0% |
Q4 2019 | $340,000 | – | 5,357 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |